Decrease of the inflammatory response and induction of the Akt/protein kinase B pathway by poly-(ADP-ribose) polymerase 1 inhibitor in endotoxin-induced septic shock

Biochemical Pharmacology

Volumn 65, Issue 8, 2003, Pages 1373-1382

  Veres, Balazs ^a   Gallyas Jr , Ferenc ^a   Varbiro, Gabor ^a   Berente, Zoltan ^a   Osz, Erzsebet ^a   Szekeres, Gyorgy ^b   Szabo, Csaba ^a,c   Sumegi, Balazs ^a  

^a UNIVERSITY OF PÉCS   (Hungary)

^b Histopathology Ltd   (Hungary)

^c INOTEK CORPORATION   (United States)

Author keywords

Akt protein kinase B; Lipopolysaccharide; MRI; Poly (ADP ribose) polymerase; Septic shock

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; N (5,6 DIHYDRO 6 OXO 2 PHENANTHRIDINYL) 2 DIMETHYLAMINOACETAMIDE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE INHIBITOR; POLY(ADENOSINE DIPHOSPHATE RIBOSE); PROTEIN KINASE B; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; BLOOD VESSEL OCCLUSION; CONTROLLED STUDY; INFLAMMATION; KIDNEY; KNOCKOUT MOUSE; LIVER; MOUSE; NECROSIS; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROPHYLAXIS; SEPTIC SHOCK; SMALL INTESTINE; STATISTICAL ANALYSIS;

EID: 0037446371     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(03)00077-7     Document Type: Article

References (37)

1. Oliver F.J., Menissier-de Murcia J., Nacci C., Decker P., Andriantsitohaina R., Muller S., de la Rubia G., Stoclet J.C., de Murcia G. Resistance to endotoxic shock as a consequence of defective NF-kappaB activation in poly(ADP-ribose) polymerase-1 deficient mice. EMBO J. 18:1999;4446-4454.
2. Soriano F.G., Liaudet L., Szabo E., Virag L., Mabley J.G., Pacher P., Szabo C. Resistance to acute septic peritonitis in poly(ADP-ribose) polymerase-1-deficient mice. Shock. 17:2002;286-292.
3. Baechtold F., Scott J.A., Markert M., Mehta S., McCormack D.G., Anglada F., Galaud D., Vaglio M., Waeber B., Feihl F. Does the activation of poly(ADP-ribose) synthetase mediate tissue injury in the sepsis induced by cecal ligation and puncture? Shock. 16:2001;137-142.
4. Albertini M., Clement M.G., Lafortuna C.L., Caniatti M., Magder S., Abdulmalek K., Hussain S.N. Role of poly-(ADP-ribose) synthetase in lipopolysaccharide-induced vascular failure and acute lung injury in pigs. J. Crit. Care. 15:2000;73-83.
5. Jagtap P., Soriano F.G., Virag L., Liaudet L., Mabley J., Szabo E., Hasko G., Marton A., Lorigados C.B., Gallyas F. Jr., Sumegi B., Hoyt D.G., Baloglu E., VanDuzer J., Salzman A.L., Southan G.J., Szabo C. Novel phenanthridinone inhibitors of poly(adenosine 5′-diphosphate-ribose) synthetase: potent cytoprotective and antishock agents. Crit. Care Med. 30:2002;1071-1082.
6. Wenzel R.P., Pinsky M.R., Ulevitch R.J., Young L. Current understanding of sepsis. Clin. Infect. Dis. 22:1996;407-412.
7. Stone R. Search for sepsis drugs goes on despite past failures. Science. 264:1994;365-367.
8. Bone R., Grodzin C., Balk R. Sepsis: a new hypothesis for pathogenesis of the disease process. Chest. 112:1997;235-243.
9. Hassa P.O., Covic M., Hasan S., Imhof R., Hottiger M.O. The enzymatic and DNA binding activity of PARP-1 are not required for NF-kappa B coactivator function. J. Biol. Chem. 276:2001;45588-45597.
10. Goldfarb R.D., Marton A., Szabo E., Virag L., Salzman A.L., Glock D., Akhter I., McCarthy R., Parrillo J.E., Szabo C. Protective effect of a novel, potent inhibitor of poly(adenosine 5′-diphosphate-ribose) synthetase in a porcine model of severe bacterial sepsis. Crit. Care Med. 30:2002;974-980.
11. Szabo C. Role of Poly(ADP-ribose) polymerase activation in the pathogenesis of shock and inflammation. In: Zhang J, editor. PARP as a therapeutic target. Boca Raton, FL: CRC Press; 2002. p. 169-204.
12. Szabo C. Poly(ADP-ribose) polymerase in the pathogenesis of circulatory shock. In: Szabo C, editor. Cell death, the role of PARP. Boca Raton, FL: CRC Press; 2000. p. 81-102.
13. Kovacs K, Toth A, Deres P, Hanto K, Hideg K, Sumegi B. Effect of poly(ADP-ribose) polymerase inhibitors on the activation of ischemia-reperfusion-induced inflammatory processes in Langendorff perfused hearts. In: Boros M, editor. Proceedings of the 37th Congress of the European Society for Surgical Research, 2002. Italy: Monduzzi Editione; 2002. p. 63-8.
14. Guha M., Mackman N. The phosphatidylinositol 3-kinase-Akt pathway limits LPS activation of signaling pathways and expression of inflammatory mediators in human monocytic cells. J. Biol. Chem. 277:2002;32124-32132.
15. Ozes O.N., Mayo L.D., Gustin J.A., Pfeffer S.R., Pfeffer L.M., Donner D.B. NF-kappaB activation by tumour necrosis factor requires the Akt serine-threonine kinase. Nature. 401:1999;82-85.
16. Hirsch E., Katanaev V.L., Garlanda C., Azzolino O., Pirola L., Silengo I., Sozzani S., Mantovani A., Altruda F., Wymann M.P. Central role for G protein-coupled phosphoinositide 3-kinase gamma in inflammation. Science. 287:2000;1049-1053.
17. Abreu M.T., Arnold E.T., Chow J.Y., Barrett K.E. Phosphatidylinositol 3-kinase-dependent pathways oppose Fas-induced apoptosis and limit chloride secretion in human intestinal epithelial cells. Implications for inflammatory diarrheal states. J. Biol. Chem. 276:2001;47563-47574.
18. Klotz L.O., Schroeder P., Sies H. Peroxynitrite signalling: receptor tyrosine kinases and activation of stress-responsive pathways. Free Radic. Biol. Med. 33:2002;737-743.
19. Bozinovski S., Jones J.E., Vlahos R., Hamilton J.A., Anderson G.P. Granulocyte/macrophage-colony-stimulating factor (GM-CSF) regulates lung innate immunity to lipopolysaccharide through Akt/Erk activation of NFkappa B and AP-1 in vivo. J. Biol. Chem. 277:2002;42808-42814.
20. Meng F., Liu L., Chin P.C., DMello S.R. Akt is a downstream target of NF-kappaB. J. Biol. Chem. 277:2002;29674-29680.
21. Szabados E., Literati N.P., Farkas B., Sumegi B. BGP-15, a nicotinic amidoxime derivate protecting heart from ischemia reperfusion injury through modulation of poly(ADP-ribose) polymerase. Biochem. Pharmacol. 59:2000;937-945.
22. Edmead C., Kanthou C., Benzakour O. Thrombin activates transcription factors sp1, NF-kappaB, and CREB: importance of the use of phosphatase inhibitors during nuclear protein extraction for the assessment of transcription factor DNA-binding activities. Anal. Biochem. 275:1999;180-186.
23. Oldner A., Goiny M., Rudehill A., Ungerstedt U., Sollevi A. Tissue hypoxanthine reflects gut vulnerability in porcine endotoxin shock. Crit. Care Med. 27:1999;790-797.
24. Epstein M.D., Banducci D.R., Manders E.K. The role of the gastrointestinal tract in the development of burn sepsis. Plast. Reconstr. Surg. 90:1992;524-531.
25. Koo D.J., Chaudry I.H., Wang P. Mechanism of hepatocellular dysfunction during sepsis: the role of gut-derived norepinephrine. Int. J. Mol. Med. 5:2000;457-465.
26. Pacher P., Cziraki A., Mabley J.G., Liaudet L., Papp L., Szabo C. Role of poly(ADP-ribose) polymerase activation in endotoxin-induced cardiac collapse in rodents. Biochem. Pharmacol. 64:2002;1785-1791.
27. Collins A.S. Gastrointestinal complications in shock. Crit. Care Nurs. Clin. North Am. 2:1990;269-277.
28. James P.E., Madhani M., Roebuck W., Jackson S.K., Swartz H.M. Endotoxin-induced liver hypoxia: defective oxygen delivery versus oxygen consumption. Nitric Oxide. 6:2002;18-28.
29. Zanetti G., Heumann D., Gerain J., Kohler J., Abbet P., Barras C., Lucas R., Glauser M.-P., Baumgartner J.-D. Cytokine production after intravenous or peritoneal Gram-negative bacterial challenge in mice. J. Immunol. 148:1992;1890-1897.
30. Barsig J., Küsters S., Vogt K., Volk H.-D., Tiegs G., Wendel A. Lipopolisaccharide-induced interleukin-10 in mice: role of endogenous tumor necrosis factor-α Eur. J. Immunol. 25:1995;2888-2893.
31. Szabo C., Cuzzocrea S., Zingarelli B., O'Connor M., Salzman A.L. Endothelial dysfunction in a rat model of endotoxic shock. Importance of the activation of poly(ADP-ribose) synthetase by peroxynitrite. J. Clin. Invest. 100:1997;723-735.
32. Zingarelli B., Scott G.S., Hake P., Salzman A.L., Szabo C. Effects of nicaraven on nitric oxide-related pathways and in shock and inflammation. Shock. 13:2000;126-134.
33. Brazil D.P., Hemmings B.A. Ten years of protein kinase B signalling: a hard Akt to follow. Trends Biochem. Sci. 26:2001;657-664.
34. Monick M.M., Carter A.B., Robeff P.K., Flatherty D.M., Peterson M.W., Hunninghake G.W. Lipopolysaccharide activates Akt in human alveolar macrophages resulting in nuclear accumulation and transcriptional activity of β-catenin. J. Immunol. 166:2001;4713-4720.
35. Zirngibl R.A., Senis Y., Greer P.A. Enhanced endotoxin sensitivity in fps/fes-null mice with minimal defects in hematopoetic homeostasis. Mol. Cell Biol. 22:2002;2472-2486.
36. Virág L., Szabó C. Therapeutic potential of PARP inhibitors. Pharmacol. Rev. 54:2002;375-419.
37. Perkins E., Sun D., Nguyen A., Tulac S., Francesco M., Tavana H., Nguyen H., Tugendreich S., Barthmeier P., Couto J., Yeh E., Thode S., Jarnagin K., Jain A., Morgans D., Melese T. Novel inhibitors of poly(ADP) polymerase/PARP1 and PARP2 identified using a cell-based screen in yeast. Cancer Res. 61:2001;4175-7183.